A retrospective cross-sectional study was performed in a DSD clinic at a tertiary service (University Hospital) to estimate the frequency of disorders of sex development (DSD) among men who seek medical care because of infertility. The sample included 84 men >20 years of age referred from 2010-2017 due to oligozoospermia or nonobstructive azoospermia of unknown etiology. Twelve cases (14%) were diagnosed as DSD, including Klinefelter Syndrome, 46,XX testicular DSD, and mild androgen insensitivity syndrome. Y chromosome microdeletions were detected in 2 patients. Among the remaining 70 cases there were patients with chromosome abnormalities which are not included in the DSD classification as well as rare NR5A1 variants of uncertain significance and hypergonadotropic hypogonadism and microorchidism in 46,XY subjects. In conclusion, the frequency of DSD in this study was 14%, consisting mainly of sex chromosome abnormalities but also 46,XX and 46,XY DSD. However, this figure may increase as further investigations are conducted in idiopathic cases with signs of primary testicular failure, which may present partial gonadal dysgenesis.

1.
Agarwal A, Mulgund A, Hamada A, Chyatte MR: A unique view on male infertility around the globe. Reprod Biol Endocrinol 13:37 (2015).
2.
Aydos SE, Tükün A: Infertility in a man with oligoasthenoteratozoospermia associated with non-Robertsonian translocation t(9;15)(p10;q10). Fertil Steril 86:1001.e7-9 (2006).
3.
Balkan M, Tekes S, Gedik A: Cytogenetic and Y chromosome microdeletion screening studies in infertile males with oligozoospermia and azoospermia in Southeast Turkey. J Assist Reprod Genet 25:559-565 (2008).
4.
Bashamboo A, Ferraz-de-Souza B, Lourenço D, Lin L, Sebire NJ, et al: Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. Am J Hum Genet 87:505-512 (2010).
5.
Bojesen A, Gravholt CH: Klinefelter syndrome in clinical practice. Nat Clin Pract Urol 4:192-204 (2007).
6.
Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HWG, et al: World Health Organization reference values for human semen characteristics. Hum Reprod Update 16:231-245 (2010).
7.
Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C: Male infertility: role of genetic background. Reprod Biomed Online 14:734-745 (2007).
8.
Ferlin A, Rocca MS, Vinanzi C, Ghezzi M, Di Nisio A, Foresta C: Mutational screening of NR5A1 gene encoding steroidogenic factor 1 in cryptorchidism and male factor infertility and functional analysis of seven undescribed mutations. Fertil Steril 104:163-169.e1 (2015).
9.
Foresta C, Moro E, Ferlin A: Y chromosome microdeletions and alterations of spermatogenesis 1. Endocr Rev 22:226-239 (2001).
10.
Gao X, Chen G, Huang J, Bai Q, Zhao N, et al: Clinical, cytogenetic, and molecular analysis with 46,XX male sex reversal syndrome: case reports. J Assist Reprod Genet 30:431-435 (2013).
11.
Guercio G, Rey RA: Fertility issues in the management of patients with disorders of sex development. Endocr Dev 27:87-98 (2014).
12.
Hellwinkel OJ, Holterhus PM, Struve D, Marschke C, Homburg N, Hiort O: A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants. J Clin Endocrinol Metab 86:2569-2575 (2001).
13.
Hiort O, Holterhus PM, Horter T, Schulze W, Kremke B, et al: Significance of mutations in the androgen receptor gene in males with idiopathic infertility. J Clin Endocrinol Metab 85:2810-2815 (2000).
14.
Hotaling J, Carrell DT: Clinical genetic testing for male factor infertility: current applications and future directions. Andrology 2:339-350 (2014).
15.
Jarow JP, Espeland MA, Lipshultz LI: Evaluation of the azoospermic patient. J Urol 142:62-65 (1989).
16.
Lee PA, Houk CP, Ahmed SF, Hughes IA, International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology: Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 118:e488-e500 (2006).
17.
Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R, et al: Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr 85:158-180 (2016).
18.
Lehmann KJ, Kovac JR, Xu J, Fischer MA: Isodicentric Yq mosaicism presenting as infertility and maturation arrest without altered SRY and AZF regions. J Assist Reprod Genet 29:939-942 (2012).
19.
Louis JF, Thoma ME, Sørensen DN, McLain AC, King RB, et al: The prevalence of couple infertility in the United States from a male perspective: evidence from a nationally representative sample. Andrology 1:741-748 (2013).
20.
Matzuk MM, Lamb DJ: The biology of infertility: research advances and clinical challenges. Nat Med 14:1197-1213 (2008).
21.
O'Flynn O'Brien KL, Varghese AC, Agarwal A: The genetic causes of male factor infertility: a review. Fertil Steril 93:1-12 (2010).
22.
Olayemi FO: A review on some causes of male infertility. African J Biotechnol 9:2834-2842 (2010).
23.
Petroli RJ, Hiort O, Struve D, Maciel-Guerra AT, Guerra-Júnior G, et al: Preserved fertility in a patient with gynecomastia associated with the p.Pro695Ser mutation in the androgen receptor. Sex Dev 8:350-355 (2014).
24.
Practice Committee of the American Society for Reproductive Medicine: Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril 103:e18-e25 (2015).
25.
Quan Q, Li TJ, Ding XP, Wei J, Li LX, Fu L: Infertility caused by male partners with genetic defects in Sichuan Province of China. Genet Mol Res 12:6512-6520 (2013).
26.
Ravel C, Chantot-Bastaraud S, El Houate B, Rouba H, Legendre M, et al: Y-chromosome AZFc structural architecture and relationship to male fertility. Fertil Steril 92:1924-1933 (2009).
27.
Reijo R, Lee TY, Salo P, Alagappan R, Brown LG, et al: Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet 10:383-393 (1995).
28.
Schultz N, Hamra FK, Garbers DL: A multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets. Proc Natl Acad Sci USA 100:12201-12206 (2003).
29.
Sudhakar DVS, Nizamuddin S, Manisha G, Devi JR, Gupta NJ, et al: NR5A1 mutations are not associated with male infertility in Indian men. Andrologia 50:e12931 (2018).
30.
Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, et al: Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet 5:933-943 (1996).
31.
Wosnitzer M, Goldstein M, Hardy MP: Review of azoospermia. Spermatogenesis 4:e28218 (2014).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.